PMC:7565482 / 24371-25470
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T109 | 237-241 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T110 | 438-442 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T111 | 809-813 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T112 | 902-906 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T113 | 929-934 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T64 | 224-232 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T65 | 826-834 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T66 | 1016-1024 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T221 | 198-201 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | aim |
| T222 | 222-223 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T223 | 233-241 | http://purl.obolibrary.org/obo/CLO_0001272 | denotes | 2 T cell |
| T224 | 242-246 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T225 | 436-442 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
| T226 | 484-487 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T227 | 530-538 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
| T228 | 641-648 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T229 | 675-678 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T230 | 745-752 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T231 | 773-774 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T232 | 807-813 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
| T233 | 900-906 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
| T234 | 927-934 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 309 | 60-65 | Species | denotes | CoV-2 | Tax:2697049 |
| 310 | 224-234 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 311 | 826-836 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 312 | 153-161 | Disease | denotes | infected | MESH:D007239 |
| 313 | 1016-1024 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T167 | 0-174 | Sentence | denotes | The present study is currently limited to the design of the CoV-2 consensus sequence, without functional immune analyses of the OLP sets in samples from infected individuals. |
| T168 | 175-387 | Sentence | denotes | However, the principal aim here was to provide a SARS-CoV-2 T cell test reagent, including all described ORF and covering as much viral variability as possible, for its implementation in future screening efforts. |
| T169 | 388-726 | Sentence | denotes | In addition, the OLP sets will certainly elicit T cell responses in vitro as partial evaluation has been performed by others in studies using peptides spanning some of the regions covered by the present consensus sequence [5,9,11] and since the current peptide designs (length, overlap) has been shown to be effective in the past [55,70]. |
| T170 | 727-1099 | Sentence | denotes | Thus, the present peptide designs will afford a high-resolution analysis of the T cell response to SARS-CoV-2, the nature of the targeted epitopes and the functionality and T cell receptor use of the T cells targeting these epitopes, thereby increasing our knowledge of factors that drive COVID-19 disease progression and which could be implemented in vaccine development. |